MapLight Therapeutics (MPLT) Share-based Compensation (2024 - 2026)
MapLight Therapeutics (MPLT) posted Share-based Compensation of $35.5 million for Q4 2025, up 28316.8% sequentially from $125000.0 in Q3 2025, and up 5638.45% YoY from $619000.0 in Q4 2024.
MapLight Therapeutics (MPLT) Share-based Compensation (2024 - 2026) Analysis & Trends
MapLight Therapeutics has reported Share-based Compensation for 2 years, with the latest figure at $35.5 million in Q4 2025.
- Quarterly Share-based Compensation rose 5638.45% year-over-year to $35.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.6 million (changed N/A YoY) and the FY2025 annual result came in at $38.2 million, up 2472.39% from the prior year.
- Share-based Compensation rose to $35.5 million in Q4 2025 per MPLT's latest filing, from $125000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $35.5 million in Q4 2025 and troughed at $125000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | MapLight Therapeutics | 533.88 Mn | 533.88 Mn | - | 42.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.00 Mn |
| Jun 30, 2026 | 42.00 Mn |
| Dec 31, 2025 | 35.52 Mn |
| Dec 31, 2025 | 35.52 Mn |
| Sep 30, 2025 | 125,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Dec 31, 2024 | 619,000.00 |
| Dec 31, 2024 | 619,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Sep 30, 2024 | 354,000.00 |